Uganda: Members of Parliament (MPs) Wants Safeguards for Government’s Shs723.4 Billion Investment in Dei BioPharma
The Committee on Presidential Affairs has called for stronger accountability, reliable utilities and clear performance targets for Dei BioPharma Limited, following a government investment of Shs723.4 billion in the pharmaceutical manufacturing project. The committee during its assessment of the company’s performance revealed that the substantial public investment in the privately operated company lacks proper documentation of the government’s shareholding, expected returns, project deliverables and measurable benefits to Ugandans. “Government should ensure that clear documentation of government’s shares in Dei BioPharma, the expected returns, deliverables and performance targets, commensurate with the public resources invested are provided,” said Hon. Martin Mapenduzi while presenting the committee’s report on its assessment of selected Science, Technology and Innovation Projects. Mapenduzi presented the report during the plenary sitting chaired by Deputy Speaker Thomas Tayebwa on Tuesday, 06 October 2026. According to the report, government provided Shs70 billion to Dei BioPharma in the 2023/2024 financial year, an additional Shs75 billion in December 2023 and Shs578.4 billion thr
Résiliable à tout moment · 99 $ CA/mois


